<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231201060234N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-07-08</date_registration>
      <primary_sponsor>CMH Peshawar</primary_sponsor>
      <public_title>Negative pressure versus standard wound therapy for diabetic foot</public_title>
      <acronym></acronym>
      <scientific_title>Comparison between negative pressure wound therapy versus standard wound care in diabetic foot patients at a tertiary care hospital</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>160</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74221</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: We made two groups of 95 patients each, one to receive standard dressing care and one to receive NPWT randomized through non-probability consecutive sampling via lottery method according to the inclusion criteria furnished. Simple randomization was done. Allocation concealment was carried out through envelopes and residents unaware of the study protocol, Blinding description: Since procedural limitations did not allow blinding during the study, the endpoint of wound healing and size regression was assessed by an independent team of 3 consultants who were given the final results of the wounds in pictorial form to give their opinion of the changes before and after treatment and debridement. Data analysis consultant was also blinded to the study protocol with data given as Group N and Group S.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Diabetic foot ulcers.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Negative pressure wound therapy group (NPWT) (n=95)                                Patients in Group N received NPWT after debridement on admission in the hospital and were followed up for 12 weeks to assess for complete healing with 100% epithelization and fit for surgical closure. A standard sub-atmospheric pressure of 120 mmHg was applied on the debrided ulcer through a sealed wound attached to a suction pump. Patients were followed up for up to 12 weeks and primary and secondary variables noted by an independent surgical consultant unaware of the study protocol. Intervention 2: Intervention group: Standard moist wound therapy group (n=95)                                                                    Patients in Group S received standard modern moist wound dressing after debridement and followed up for the same after complete epithelization and tissue formation for up to 12 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The word file along with SPSS data set and output sheet would be shared once the article gets accepted and published

When:
Will be available after manuscript approval and would be able to download and use for five years

To whom:
only for academic purposes

Conditions:
will be provided after official approval from primary author through email and link would be sent to download the data set from online backup repository

Where to obtain:
Application to access data through official email of the primary author provided in the trial

How to obtain:
will be provided after official approval from primary author through email and link would be sent to download the data set from online backup repository
total time would be 7-10 working days

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Rashid Ali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>D7</address>
        <city>Rawalpindi</city>
        <country1>Pakistan</country1>
        <zip>46000</zip>
        <telephone>+92 81 2850639</telephone>
        <email>Rashid_zahidbaloch@hotmail.com</email>
        <affiliation>CMH Rwp</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rashid Ali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>D7</address>
        <city>Rawalpindi</city>
        <country1>Pakistan</country1>
        <zip>46000</zip>
        <telephone>+92 81 2850639</telephone>
        <email>Rashid_zahidbaloch@hotmail.com</email>
        <affiliation>CMH Rwp</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Included all patients &gt;18 years diagnosed clinically and BSF and 2-hour-post prandial investigations in the diabetic range according to the WHO criteria
Presenting with a diabetic foot wound of more than 4 weeks duration corresponding to Wagner grade 2 for debridement.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Included patients &lt; 18 years
Pregnancy
Non-compliant to follow-up
Necrotic tissue on ulcer with eschar that could not be debrided
Malignancy, advanced cardiac and respiratory disease
Exposed nerve and vessels beneath the ulcer and patient with above ankle ulcer and those with Charcot arthropathy.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z86.31</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Personal history of diabetic foot ulcer</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Negative pressure wound therapy group (NPWT) (n=95)                                Patients in Group N received NPWT after debridement on admission in the hospital and were followed up for 12 weeks to assess for complete healing with 100% epithelization and fit for surgical closure. A standard sub-atmospheric pressure of 120 mmHg was applied on the debrided ulcer through a sealed wound attached to a suction pump. Patients were followed up for up to 12 weeks and primary and secondary variables noted by an independent surgical consultant unaware of the study protocol.</i_keyword>
      <i_keyword>Intervention group: Standard moist wound therapy group (n=95)                                                                    Patients in Group S received standard modern moist wound dressing after debridement and followed up for the same after complete epithelization and tissue formation for up to 12 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mean wound closure time. Timepoint: During or after 12 weeks of therapy. Method of measurement: Subjective assessment by 3 consultants.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Median pain scores. Timepoint: After 12 weeks of therapy. Method of measurement: Standard Visual Analog Scale for pain and Likert scale for satisfaction.</sec_outcome>
      <sec_outcome>Incidence of infection. Timepoint: During 12 weeks of therapy. Method of measurement: Subjective by 3 independent consultants.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>CMH Peshawar</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-22</approval_date>
        <contact_name>Ethical review board CMH Peshawar</contact_name>
        <contact_address>CMH Road Peshawar KPK Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
